Selected research
Industry Research
Absorbable Hemostatic Materials Industry Research Report 2026
Market perspective
The global Absorbable Hemostatic Materials market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Absorbable Hemostatic Materials market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Absorbable Hemostatic Materials market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Absorbable Hemostatic Materials market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Absorbable Hemostatic Materials include Johnson & Johnson, Guizhou Jin Jiu Biotech, B.Braun, Beijing Taikesiman, Beijing Datsing Bio-tech, Baxter, Zhonghui Shengxi, Saikesaisi Holdings Group and Meril Life Sciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Absorbable Hemostatic Materials market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Absorbable Hemostatic Materials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Absorbable Hemostatic Materials Market by Company
Johnson & Johnson
Guizhou Jin Jiu Biotech
B.Braun
Beijing Taikesiman
Beijing Datsing Bio-tech
Baxter
Zhonghui Shengxi
Saikesaisi Holdings Group
Meril Life Sciences
GELITA MEDICAL
Foryou Medical
Curasan AG
Cura Medical
Biotemed
BD
Absorbable Hemostatic Materials Segment by Type
Absorbable Hemostat Powder
Absorbable Hemostat Gauze
Absorbable Hemostat Gelatin Sponge
Others
Absorbable Hemostatic Materials Segment by Application
Hospitals
Clinics
Others
Absorbable Hemostatic Materials Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Materials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Absorbable Hemostatic Materials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Absorbable Hemostat Powder
- Absorbable Hemostat Gauze
- Absorbable Hemostat Gelatin Sponge
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Johnson & Johnson
- Guizhou Jin Jiu Biotech
- B.Braun
- Beijing Taikesiman
- Beijing Datsing Bio-tech
- Baxter
- Zhonghui Shengxi
- Saikesaisi Holdings Group
- Meril Life Sciences
- GELITA MEDICAL
- Foryou Medical
- Curasan AG
- Cura Medical
- Biotemed
- BD
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Absorbable Hemostatic Materials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Absorbable Hemostat Powder
- 2.2.3 Absorbable Hemostat Gauze
- 2.2.4 Absorbable Hemostat Gelatin Sponge
- 2.2.5 Others
- 2.3 Absorbable Hemostatic Materials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Absorbable Hemostatic Materials Breakdown Data by Type
- 3.1 Global Absorbable Hemostatic Materials Historic Market Size by Type (2021-2026)
- 3.2 Global Absorbable Hemostatic Materials Forecasted Market Size by Type (2027-2032)
4 Absorbable Hemostatic Materials Breakdown Data by Application
- 4.1 Global Absorbable Hemostatic Materials Historic Market Size by Application (2021-2026)
- 4.2 Global Absorbable Hemostatic Materials Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Absorbable Hemostatic Materials Market Perspective (2021-2032)
- 5.2 Global Absorbable Hemostatic Materials Growth Trends by Region
- 5.2.1 Global Absorbable Hemostatic Materials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Absorbable Hemostatic Materials Historic Market Size by Region (2021-2026)
- 5.2.3 Absorbable Hemostatic Materials Forecasted Market Size by Region (2027-2032)
- 5.3 Absorbable Hemostatic Materials Market Dynamics
- 5.3.1 Absorbable Hemostatic Materials Industry Trends
- 5.3.2 Absorbable Hemostatic Materials Market Drivers
- 5.3.3 Absorbable Hemostatic Materials Market Challenges
- 5.3.4 Absorbable Hemostatic Materials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Absorbable Hemostatic Materials Players by Revenue
- 6.1.1 Global Top Absorbable Hemostatic Materials Players by Revenue (2021-2026)
- 6.1.2 Global Absorbable Hemostatic Materials Revenue Market Share by Players (2021-2026)
- 6.2 Global Absorbable Hemostatic Materials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Absorbable Hemostatic Materials Head Office and Area Served
- 6.4 Global Absorbable Hemostatic Materials Players, Product Type & Application
- 6.5 Global Absorbable Hemostatic Materials Manufacturers Established Date
- 6.6 Global Absorbable Hemostatic Materials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Absorbable Hemostatic Materials Market Size (2021-2032)
- 7.2 North America Absorbable Hemostatic Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Absorbable Hemostatic Materials Market Size by Country (2021-2026)
- 7.4 North America Absorbable Hemostatic Materials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Absorbable Hemostatic Materials Market Size (2021-2032)
- 8.2 Europe Absorbable Hemostatic Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Absorbable Hemostatic Materials Market Size by Country (2021-2026)
- 8.4 Europe Absorbable Hemostatic Materials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Absorbable Hemostatic Materials Market Size (2021-2032)
- 9.2 Asia-Pacific Absorbable Hemostatic Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Absorbable Hemostatic Materials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Absorbable Hemostatic Materials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Absorbable Hemostatic Materials Market Size (2021-2032)
- 10.2 South America Absorbable Hemostatic Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Absorbable Hemostatic Materials Market Size by Country (2021-2026)
- 10.4 South America Absorbable Hemostatic Materials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Absorbable Hemostatic Materials Market Size (2021-2032)
- 11.2 Middle East & Africa Absorbable Hemostatic Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Absorbable Hemostatic Materials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Absorbable Hemostatic Materials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.1.4 Johnson & Johnson Absorbable Hemostatic Materials Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 Guizhou Jin Jiu Biotech
- 12.2.1 Guizhou Jin Jiu Biotech Company Information
- 12.2.2 Guizhou Jin Jiu Biotech Business Overview
- 12.2.3 Guizhou Jin Jiu Biotech Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.2.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Product Portfolio
- 12.2.5 Guizhou Jin Jiu Biotech Recent Developments
- 12.3 B.Braun
- 12.3.1 B.Braun Company Information
- 12.3.2 B.Braun Business Overview
- 12.3.3 B.Braun Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.3.4 B.Braun Absorbable Hemostatic Materials Product Portfolio
- 12.3.5 B.Braun Recent Developments
- 12.4 Beijing Taikesiman
- 12.4.1 Beijing Taikesiman Company Information
- 12.4.2 Beijing Taikesiman Business Overview
- 12.4.3 Beijing Taikesiman Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.4.4 Beijing Taikesiman Absorbable Hemostatic Materials Product Portfolio
- 12.4.5 Beijing Taikesiman Recent Developments
- 12.5 Beijing Datsing Bio-tech
- 12.5.1 Beijing Datsing Bio-tech Company Information
- 12.5.2 Beijing Datsing Bio-tech Business Overview
- 12.5.3 Beijing Datsing Bio-tech Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.5.4 Beijing Datsing Bio-tech Absorbable Hemostatic Materials Product Portfolio
- 12.5.5 Beijing Datsing Bio-tech Recent Developments
- 12.6 Baxter
- 12.6.1 Baxter Company Information
- 12.6.2 Baxter Business Overview
- 12.6.3 Baxter Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.6.4 Baxter Absorbable Hemostatic Materials Product Portfolio
- 12.6.5 Baxter Recent Developments
- 12.7 Zhonghui Shengxi
- 12.7.1 Zhonghui Shengxi Company Information
- 12.7.2 Zhonghui Shengxi Business Overview
- 12.7.3 Zhonghui Shengxi Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.7.4 Zhonghui Shengxi Absorbable Hemostatic Materials Product Portfolio
- 12.7.5 Zhonghui Shengxi Recent Developments
- 12.8 Saikesaisi Holdings Group
- 12.8.1 Saikesaisi Holdings Group Company Information
- 12.8.2 Saikesaisi Holdings Group Business Overview
- 12.8.3 Saikesaisi Holdings Group Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Materials Product Portfolio
- 12.8.5 Saikesaisi Holdings Group Recent Developments
- 12.9 Meril Life Sciences
- 12.9.1 Meril Life Sciences Company Information
- 12.9.2 Meril Life Sciences Business Overview
- 12.9.3 Meril Life Sciences Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.9.4 Meril Life Sciences Absorbable Hemostatic Materials Product Portfolio
- 12.9.5 Meril Life Sciences Recent Developments
- 12.10 GELITA MEDICAL
- 12.10.1 GELITA MEDICAL Company Information
- 12.10.2 GELITA MEDICAL Business Overview
- 12.10.3 GELITA MEDICAL Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.10.4 GELITA MEDICAL Absorbable Hemostatic Materials Product Portfolio
- 12.10.5 GELITA MEDICAL Recent Developments
- 12.11 Foryou Medical
- 12.11.1 Foryou Medical Company Information
- 12.11.2 Foryou Medical Business Overview
- 12.11.3 Foryou Medical Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.11.4 Foryou Medical Absorbable Hemostatic Materials Product Portfolio
- 12.11.5 Foryou Medical Recent Developments
- 12.12 Curasan AG
- 12.12.1 Curasan AG Company Information
- 12.12.2 Curasan AG Business Overview
- 12.12.3 Curasan AG Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.12.4 Curasan AG Absorbable Hemostatic Materials Product Portfolio
- 12.12.5 Curasan AG Recent Developments
- 12.13 Cura Medical
- 12.13.1 Cura Medical Company Information
- 12.13.2 Cura Medical Business Overview
- 12.13.3 Cura Medical Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.13.4 Cura Medical Absorbable Hemostatic Materials Product Portfolio
- 12.13.5 Cura Medical Recent Developments
- 12.14 Biotemed
- 12.14.1 Biotemed Company Information
- 12.14.2 Biotemed Business Overview
- 12.14.3 Biotemed Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.14.4 Biotemed Absorbable Hemostatic Materials Product Portfolio
- 12.14.5 Biotemed Recent Developments
- 12.15 BD
- 12.15.1 BD Company Information
- 12.15.2 BD Business Overview
- 12.15.3 BD Revenue in Absorbable Hemostatic Materials Business (2021-2026)
- 12.15.4 BD Absorbable Hemostatic Materials Product Portfolio
- 12.15.5 BD Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst